Gene · 4607
Papers3,985
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
461 to 480 of 3,985
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Successes and challenges of artificial intelligence in cardiology. | Front Digit Health | 2023 | 37448836 | PubTator, text mining | PubMed |
| An Update on MYBPC3 Gene Mutation in Hypertrophic Cardiomyopathy. | Int J Mol Sci | 2023 | 37445689 | PubTator, text mining | PubMed |
| EMQN: Recommendations for genetic testing in inherited cardiomyopathies and arrhythmias. | Eur J Hum Genet | 2023 | 37443332 | PubTator, text mining | PubMed |
| Cytoskeletal disarray increases arrhythmogenic vulnerability during sympathetic stimulation in a model of hypertrophic cardiomyopathy. | Sci Rep | 2023 | 37438479 | PubTator, text mining | PubMed |
| AKR1C1 overexpression leads to lenvatinib resistance in hepatocellular carcinoma. | J Gastrointest Oncol | 2023 | 37435231 | PubTator, text mining | PubMed |
| A novel αB-crystallin R123W variant drives hypertrophic cardiomyopathy by promoting maladaptive calcium-dependent signal transduction. | Front Cardiovasc Med | 2023 | 37435054 | PubTator, text mining | PubMed |
| Ethnicity, consanguinity, and genetic architecture of hypertrophic cardiomyopathy. | Eur Heart J | 2023 | 37431535 | PubTator, text mining | PubMed |
| Application of next generation sequencing in cardiology: current and future precision medicine implications. | Front Cardiovasc Med | 2023 | 37424920 | PubTator, text mining | PubMed |
| Evolving cardiovascular genetic counseling needs in the era of precision medicine. | Front Cardiovasc Med | 2023 | 37424912 | PubTator, text mining | PubMed |
| Long-Term Prevalence of Systolic Dysfunction in MYBPC3 Versus MYH7-Related Hypertrophic Cardiomyopathy. | Circ Genom Precis Med | 2023 | 37409452 | PubTator, text mining | PubMed |
| Transcriptome-Powered Pluripotent Stem Cell Differentiation for Regenerative Medicine. | Cells | 2023 | 37408278 | PubTator, text mining | PubMed |
| Causal associations between cardiorespiratory fitness and type 2 diabetes. | Nat Commun | 2023 | 37400433 | PubTator, text mining | PubMed |
| A novel compound heterozygous variant in ALPK3 induced hypertrophic cardiomyopathy: a case report. | Front Cardiovasc Med | 2023 | 37396576 | PubTator, text mining | PubMed |
| Should young athletes be screened for cardiomyopathies to reduce the burden of sudden cardiac death in athletes? | Biophys Rev | 2023 | 37396442 | PubTator, text mining | PubMed |
| A Rare Mechanism for Spontaneous Closure of Muscular Ventricular Septal Defect in Hypertrophic Cardiomyopathy. | JACC Case Rep | 2023 | 37396317 | PubTator, text mining | PubMed |
| A Case Series of Patients With MYBPC1 Gene Variants Featuring Undulating Tongue Movements as Myogenic Tremor. | Pediatr Neurol | 2023 | 37392669 | PubTator, text mining | PubMed |
| Validation of protein biological markers of lamb meat quality characteristics based on the different muscle types. | Food Chem | 2023 | 37392625 | PubTator, text mining | PubMed |
| Characterization of the circulating transcriptome expression profile and identification of novel miRNA biomarkers in hypertrophic cardiomyopathy. | Eur J Med Res | 2023 | 37391825 | PubTator, text mining | PubMed |
| Childhood Hypertrophic Cardiomyopathy Caused by Beta-Myosin Heavy Chain Variants Is Associated With a More Obstructive but Less Arrhythmogenic Phenotype Than Myosin-Binding Protein C Disease. | Circ Genom Precis Med | 2023 | 37387224 | PubTator, text mining | PubMed |
| Clinical Trials in Hypertrophic Cardiomyopathy Therapy: A Comprehensive Analysis of Trials Registered in Global Clinical Databases. | Drug Des Devel Ther | 2023 | 37377648 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4607/papers?page=24